Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 1
2009 1
2011 1
2012 1
2014 2
2015 4
2016 3
2017 4
2018 1
2019 5
2020 12
2021 15
2022 9
2023 8
2024 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Intravascular Complications of Central Venous Catheterization by Insertion Site.
Parienti JJ, Mongardon N, Mégarbane B, Mira JP, Kalfon P, Gros A, Marqué S, Thuong M, Pottier V, Ramakers M, Savary B, Seguin A, Valette X, Terzi N, Sauneuf B, Cattoir V, Mermel LA, du Cheyron D; 3SITES Study Group. Parienti JJ, et al. N Engl J Med. 2015 Sep 24;373(13):1220-9. doi: 10.1056/NEJMoa1500964. N Engl J Med. 2015. PMID: 26398070 Free article. Clinical Trial.
Kidney organoid models reveal cilium-autophagy metabolic axis as a therapeutic target for PKD both in vitro and in vivo.
Liu M, Zhang C, Gong X, Zhang T, Lian MM, Chew EGY, Cardilla A, Suzuki K, Wang H, Yuan Y, Li Y, Naik MY, Wang Y, Zhou B, Soon WZ, Aizawa E, Li P, Low JH, Tandiono M, Montagud E, Moya-Rull D, Rodriguez Esteban C, Luque Y, Fang M, Khor CC, Montserrat N, Campistol JM, Izpisua Belmonte JC, Foo JN, Xia Y. Liu M, et al. Among authors: luque y. Cell Stem Cell. 2024 Jan 4;31(1):52-70.e8. doi: 10.1016/j.stem.2023.12.003. Cell Stem Cell. 2024. PMID: 38181751
In vivo partial reprogramming alters age-associated molecular changes during physiological aging in mice.
Browder KC, Reddy P, Yamamoto M, Haghani A, Guillen IG, Sahu S, Wang C, Luque Y, Prieto J, Shi L, Shojima K, Hishida T, Lai Z, Li Q, Choudhury FK, Wong WR, Liang Y, Sangaraju D, Sandoval W, Esteban CR, Delicado EN, Garcia PG, Pawlak M, Vander Heiden JA, Horvath S, Jasper H, Izpisua Belmonte JC. Browder KC, et al. Among authors: luque y. Nat Aging. 2022 Mar;2(3):243-253. doi: 10.1038/s43587-022-00183-2. Epub 2022 Mar 7. Nat Aging. 2022. PMID: 37118377
The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment.
Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon SS, Kavanagh D, Haller H; 311 Study Group. Rondeau E, et al. Kidney Int. 2020 Jun;97(6):1287-1296. doi: 10.1016/j.kint.2020.01.035. Epub 2020 Mar 6. Kidney Int. 2020. PMID: 32299680 Free article. Clinical Trial.
Exome-First Strategy in Adult Patients With CKD: A Cohort Study.
Doreille A, Lombardi Y, Dancer M, Lamri R, Testard Q, Vanhoye X, Lebre AS, Garcia H, Rafat C, Ouali N, Luque Y, Izzedine H, Esteve E, Cez A, Petit-Hoang C, François H, Marchal A, Letavernier E, Frémeaux-Bacchi V, Boffa JJ, Rondeau E, Raymond L, Mesnard L. Doreille A, et al. Among authors: luque y. Kidney Int Rep. 2022 Dec 17;8(3):596-605. doi: 10.1016/j.ekir.2022.12.007. eCollection 2023 Mar. Kidney Int Rep. 2022. PMID: 36938085 Free PMC article.
Penile Calciphylaxis.
Gaillet A, Luque Y. Gaillet A, et al. Among authors: luque y. Urology. 2020 Jun;140:e8-e9. doi: 10.1016/j.urology.2020.03.003. Epub 2020 Mar 16. Urology. 2020. PMID: 32194088
Simulation-based learning in nephrology.
Maisons V, Lanot A, Luque Y, Sautenet B, Esteve E, Guillouet E, François H, Bobot M. Maisons V, et al. Among authors: luque y. Clin Kidney J. 2024 Mar 12;17(4):sfae059. doi: 10.1093/ckj/sfae059. eCollection 2024 Apr. Clin Kidney J. 2024. PMID: 38680455 Free PMC article. Review.
Long-Term Efficacy and Safety of the Long-Acting Complement C5 Inhibitor Ravulizumab for the Treatment of Atypical Hemolytic Uremic Syndrome in Adults.
Barbour T, Scully M, Ariceta G, Cataland S, Garlo K, Heyne N, Luque Y, Menne J, Miyakawa Y, Yoon SS, Kavanagh D; 311 Study Group Members. Barbour T, et al. Among authors: luque y. Kidney Int Rep. 2021 Mar 24;6(6):1603-1613. doi: 10.1016/j.ekir.2021.03.884. eCollection 2021 Jun. Kidney Int Rep. 2021. PMID: 34169200 Free PMC article.
Eculizumab and aHUS: Spotlight on Patient-Centered Care.
Rafat C, Luque Y. Rafat C, et al. Among authors: luque y. Kidney Int Rep. 2020 Jun 17;5(8):1123-1125. doi: 10.1016/j.ekir.2020.06.007. eCollection 2020 Aug. Kidney Int Rep. 2020. PMID: 32779641 Free PMC article. No abstract available.
Vancomycin-Associated Cast Nephropathy.
Luque Y, Louis K, Jouanneau C, Placier S, Esteve E, Bazin D, Rondeau E, Letavernier E, Wolfromm A, Gosset C, Boueilh A, Burbach M, Frère P, Verpont MC, Vandermeersch S, Langui D, Daudon M, Frochot V, Mesnard L. Luque Y, et al. J Am Soc Nephrol. 2017 Jun;28(6):1723-1728. doi: 10.1681/ASN.2016080867. Epub 2017 Jan 12. J Am Soc Nephrol. 2017. PMID: 28082518 Free PMC article.
67 results